INOTIV INC (NOTV) Stock Price, Quote, News and Overview
NASDAQ:NOTV - Nasdaq - US45783Q1004 - Common Stock - Currency: USD
NOTV Quote, Performance and Key Statistics
NASDAQ:NOTV (4/23/2025, 4:05:12 PM)
1.77
+0.12 (+7.27%)
The current stock price of NOTV is 1.77 USD. In the past month the price decreased by -31.4%. In the past year, price decreased by -56.3%.
NOTV Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| TMO | THERMO FISHER SCIENTIFIC INC | 19.75 | 162.94B | ||
| DHR | DANAHER CORP | 26.35 | 140.45B | ||
| A | AGILENT TECHNOLOGIES INC | 19.77 | 29.94B | ||
| IQV | IQVIA HOLDINGS INC | 13.2 | 25.93B | ||
| MTD | METTLER-TOLEDO INTERNATIONAL | 25.42 | 21.80B | ||
| WAT | WATERS CORP | 28.21 | 19.92B | ||
| WST | WEST PHARMACEUTICAL SERVICES | 32.32 | 15.77B | ||
| ILMN | ILLUMINA INC | 31.12 | 12.07B | ||
| ICLR | ICON PLC | 10.22 | 11.82B | ||
| RVTY | REVVITY INC | 19.12 | 11.26B | ||
| AVTR | AVANTOR INC | 15.47 | 10.54B | ||
| QGEN | QIAGEN N.V. | 19.15 | 9.15B |
Related stock screener links
About NOTV
Company Profile
Inotiv, Inc. is a pharmaceutical development company, which engages in the provision of nonclinical and analytical drug discovery and development services primarily to the pharmaceutical and medical device industries and selling a range of research-quality animals and diets to academia and government clients. The company is headquartered in West Lafayette, Indiana and currently employs 1,977 full-time employees. Its products and services focus on bringing new drugs and medical devices through the discovery and preclinical phases of development. The company operates through two segments: Discovery and Safety Assessment (DSA) and Research Models and Services (RMS). Through DSA segment, it supports the discovery, nonclinical development and clinical development needs of researchers and clinicians for primarily small molecule drug candidates, as well as biotherapeutics and biomedical devices. Through RMS segment, it offers access to a range of small and large research models for basic research and drug discovery and development, as well as specialized models for specific diseases and therapeutic areas.
Company Info
INOTIV INC
2701 Kent Ave
West Lafayette INDIANA 47906 US
CEO: Robert W. Leasure Jr.
Employees: 2005
Company Website: https://www.inotivco.com/
Investor Relations: https://www.basinc.com/invest
Phone: 13174634527
INOTIV INC / NOTV FAQ
What is the stock price of INOTIV INC today?
The current stock price of NOTV is 1.77 USD. The price increased by 7.27% in the last trading session.
What is the ticker symbol for INOTIV INC stock?
The exchange symbol of INOTIV INC is NOTV and it is listed on the Nasdaq exchange.
On which exchange is NOTV stock listed?
NOTV stock is listed on the Nasdaq exchange.
What is the price forecast or stock price prediction for INOTIV INC stock?
9 analysts have analysed NOTV and the average price target is 6.29 USD. This implies a price increase of 255.37% is expected in the next year compared to the current price of 1.77. Check the INOTIV INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is INOTIV INC worth?
INOTIV INC (NOTV) has a market capitalization of 59.95M USD. This makes NOTV a Micro Cap stock.
How many employees does INOTIV INC have?
INOTIV INC (NOTV) currently has 2005 employees.
What are the support and resistance levels for INOTIV INC (NOTV) stock?
INOTIV INC (NOTV) has a support level at 1.61 and a resistance level at 2.53. Check the full technical report for a detailed analysis of NOTV support and resistance levels.
Is INOTIV INC (NOTV) expected to grow?
The Revenue of INOTIV INC (NOTV) is expected to grow by 6.93% in the next year. Check the estimates tab for more information on the NOTV EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy INOTIV INC (NOTV) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of NOTV, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of NOTV, evaluating the profitability, health, valuation and growth aspects
- INOTIV INC (NOTV) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- INOTIV INC (NOTV) Sales and EPS estimates to see what analysts future expectations are.
- INOTIV INC (NOTV) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- INOTIV INC (NOTV) Insider and Institutional Ownership to learn about the owners and their transactions.
- INOTIV INC (NOTV) Stock Chart to make your own analysis
- INOTIV INC (NOTV) Latest news and press-releases to stay up to date.
Does INOTIV INC (NOTV) stock pay dividends?
NOTV does not pay a dividend.
When does INOTIV INC (NOTV) report earnings?
INOTIV INC (NOTV) will report earnings on 2025-05-14.
What is the Price/Earnings (PE) ratio of INOTIV INC (NOTV)?
INOTIV INC (NOTV) does not have a PE ratio as the earnings reported over the last twelve months were negative (-4.61).
What is the Short Interest ratio of INOTIV INC (NOTV) stock?
The outstanding short interest for INOTIV INC (NOTV) is 6.51% of its float. Check the ownership tab for more information on the NOTV short interest.
NOTV Technical Analysis
NOTV Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to NOTV. NOTV may be in some trouble as it scores bad on both profitability and health.
NOTV Financial Highlights
Over the last trailing twelve months NOTV reported a non-GAAP Earnings per Share(EPS) of -4.61. The EPS decreased by -254.62% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -15.61% | ||
| ROE | -71.06% | ||
| Debt/Equity | 2.31 |
NOTV Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 80% to NOTV. The Buy consensus is the average rating of analysts ratings from 9 analysts.
For the next year, analysts expect an EPS growth of 40.72% and a revenue growth 6.93% for NOTV